Assessing therapeutic safety and efficacy of Pazopanib, Pembrolizumab plus Axitinib and Nivolumab plus Ipilimumab in Renal Cell Carcinoma: a systematic review and meta-analysis
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
第一著者: | Shawn, Ibna Hasan |
---|---|
その他の著者: | Jamiruddin, Mohd. Raeed |
フォーマット: | 学位論文 |
言語: | English |
出版事項: |
Brac University
2024
|
主題: | |
オンライン・アクセス: | http://hdl.handle.net/10361/23931 |
類似資料
-
A review on Metastatic Melanoma combination therapy Ipilimumab-Nivolumab
著者:: Chakraborty, Anupama
出版事項: (2024) -
Investigation of adverse effects of oral voriconazole in the treatment of fungal infection using The FDA Adverse Event Reporting System (FAERS)
著者:: Onanna, Kazi
出版事項: (2024) -
Oral terbinafine-, fluconazole-, ravuconazole-, oteseconazole-induced hepatotoxicity and acute kidney injury in the treatment of onychomycosis: a pharmacovigilance study
著者:: Rahman, Towsifur
出版事項: (2024) -
A review on combinatorial therapies in Melanoma
著者:: Ahmmed, Md. Kawsar
出版事項: (2024) -
Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
著者:: Khandker, Tahia Anjum
出版事項: (2024)